The Biostatistics Core (Core C) will bridge the transition from the DIAN database stored and managed by the Informatics Core (Core H) to the analyses of the longitudinal data within, between, and among the various data domains, the latter of which serves as the primary responsibility of the Core. Specifically the Biostatistics Core will: (1) oversee the statistical quality control of data for the study and produce appropriately de-identified and statistically analyzable datasets for distribution/analysis;(2) lead the statistical data analyses and collaborate in report preparation for all Cores and projects, and consult on the design of all projects and on the application of appropriate statistical and methodological techniques;(3) develop and implement appropriate statistical models for longitudinal changes in potential markers and use these models to test the statistical hypotheses about the preclinical changes of AD and about the temporal difference on preclinical changes of AD among various markers, and (4) serve as an advisory group for other researchers interested in using the DIAN database for additional analyses. The Biostatistics core will achieve these specific aims through extensive interactions and collaborations with all other components of DIAN.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AG032438-02
Application #
7880564
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
2
Fiscal Year
2009
Total Cost
$56,760
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Schindler, Suzanne E; Sutphen, Courtney L; Teunissen, Charlotte et al. (2018) Upward drift in cerebrospinal fluid amyloid ? 42 assay values for more than 10 years. Alzheimers Dement 14:62-70
Buckley, Rachel F; Mormino, Elizabeth C; Amariglio, Rebecca E et al. (2018) Sex, amyloid, and APOE ?4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement 14:1193-1203
Petok, Jessica R; Myers, Catherine E; Pa, Judy et al. (2018) Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers. Neurobiol Aging 65:149-157
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Gordon, Brian A; Blazey, Tyler M; Su, Yi et al. (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol 17:241-250
Day, Gregory S; Musiek, Erik S; Morris, John C (2018) Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Dis Assoc Disord 32:291-297
Villeneuve, Sylvia; Vogel, Jacob W; Gonneaud, Julie et al. (2018) Proximity to Parental Symptom Onset and Amyloid-? Burden in Sporadic Alzheimer Disease. JAMA Neurol 75:608-619
Lim, Yen Ying; Hassenstab, Jason; Goate, Alison et al. (2018) Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease. Ann Neurol 84:424-435
Schindler, Suzanne E; Gray, Julia D; Gordon, Brian A et al. (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460-1469
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17

Showing the most recent 10 out of 108 publications